- 1. guidelines.moz.gov.ua.
- 2. http://www.ncbi.nlm.nih.gov.
- 3. Shahrabi-Farahani Sh., Aguirre S. (2023) Herpesvirus-Related Lesions of the Oral Mucosa. Oral. Maxillofac. Surg. Clin. North Am., 35(2): 175–178. doi.org/10.1016/j.coms.2022.10.012.
- 4. Carneiro V.C. de S., Pereira J.G., Paula V.S. (2022) Family Herpesviridae and neuroinfections: current status and research in progress. Men. Inst. Oswaldo Cruz., 117: e220200. doi.org/10.1590/0074-02760220200.
- 5. Ziqing J., Dong Zh., Lin Zh., Jing Xu. (2025) Animal models of human herpesvirus infection. Animal Model Exp. Med. doi.org/10.1002/ame2.12575.
- 6. Gundamraj V., Hasbun R. (2023) Viral meningitis and encephalitis: an update. Curr. Opin Infect. Dis., 36(3): 177–185. doi.org/10.1097/QCO.0000000000000922.
- 7. Shan R.A., Limmer A.L., Nwannunu C.E. et al. (2019) SHingrix for Herpes Zoster: A Review. Skin Therapy Lett., 24(4): 5–7.
- 8. Kennedy P.G.E. (2023) The Spectrum of Neurological manifestations of Varicella-Zoster Virus Reactivation. Viruses, 15(8): 1663. doi.org/10.3390/v15081663.
- 9. Luwen Zh. (2023) A common mechanism links Epstein-Barr virus infections and autoimmune diseases. J. Med. Virol., 95(1): e28363. doi.org/10.1002/jmv.28363.
- 10. Huang Sh., Yasuda T. (2021) Pathologically Relevant Mouse Models for Epstein-Barr Virus-Associated B Cell Lymphoma. Front. Immunol., 12: 639844. doi.org/10.3389/fimmu.2021.639844.
- 11. Cohen J.I., Meyts I. (2020) Editorial: EBV Infection and Human Primary Immune Deficiencies. Front Immunol., 11: 130. doi.org/10.3389/fimmu.2020.00130.
- 12. Erira A.T., Navarro A.F.R., Robayo D.A.G. (2021) Human papillomavirua, Epstein-Barr virus, and Candida albicans co-infection in oral leukoplakia with different degrees of dysplasia. Clin. Exp. Dent. Res., 7(5): 914–923. doi.org/10.1002/cre2.435.
- 13. Mohammed F., Fairozekhan A.T. (2020) Oral leukoplakia. StatPearls. http://www.ncbi.nlm.nih.gov/books/NBK442013.
- 14. Kararioulaki M., Schauer F. (2024) Oral Hairy Leukoplakia. N. Engl. J. Med., 391(24): 2360. DOI: 10.1056/NEJMicm2410115.
- 15. Abati S., Bramati Ch., Bondi S. et al. (2020) Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis. Int. J. Environ. Res. Public Health, 17(24): 9160. DOI: 10.3390/ijerph17249160.
- 16. Kadnur H.B., Reddy H.C., Wanve B. et al. (2024) Kaposi’s sarcoma unmasked by corticosteroids in an advanced HIV patient with tuberculisis immune reconstitution inflammatory syndrome. Indian J. of Sex Transm. Dis. AIDS, 45(2): 141–143. doi.org/10.4103/ijstd.ijstd_8_24.
- 17. Iftode N., Radulescu M.A., Arama S.S., Arama V. (2020) Update on Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) — revive. Rom. J. of Inter. Med., 58(4): 199–208. doi.org/10.2478/rjim-2020-0017.
- 18. Dauguet M., Lebbe C., Vignes S. (2023) Lymphedema and Kaposi sarcoma: A narrative review. J. Med. Vasc., 48(5–6): 181–187. doi.org/10.1016/j.jdmv.2023.10.007.
- 19. Patel R., Lurain K., Yarchoan R., Ramaswami R. (2023) Clinical management of Kaposi sarcoma herpesvirus-associated diseases: an update on disease manifestations and treatment strategies. Expert Rev. Antiinfect. Ther., 21(9): 929–941. doi.org/10.1080/14787210.2247161.
- 20. Liew Y.Ch.Ch., Tam Y.Ch.S., Oh Ch.Ch. (2022) Treatments for AIDS/HIV-related Kaposi sarcoma: A systematic review of the literature. Int. J. Dermatol., 61(11): 1311–1324. doi.org/10.1111/ijd.16318.
|